Citations (79)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Geir Hetland, Magne Kristoffer Fagerhol, Veselka Petrova Dimova-Svetoslavova, Mohammad Reza Mirlashari, Nhan Trung Nguyen, Andreas Lind, Svein Olav Kolset, Arne Vasli Lund Søraas & Lise Sofie Haug Nissen-Meyer. (2022) Inflammatory markers calprotectin, NETs, syndecan-1 and neopterin in COVID-19 convalescent blood donors. Scandinavian Journal of Clinical and Laboratory Investigation 82:6, pages 481-485.
Read now
Read now
Ulla Bregendahl Nielsen, Laerke Valsøe Bruhn, Torkell Ellingsen, Kristian Stengaard-Pedersen & Nete Hornung. (2018) Calprotectin in patients with chronic rheumatoid arthritis correlates with disease activity and responsiveness to methotrexate. Scandinavian Journal of Clinical and Laboratory Investigation 78:1-2, pages 62-67.
Read now
Read now
Judith Austermann, Stefanie Zenker & Johannes Roth. (2017) S100-alarmins: potential therapeutic targets for arthritis. Expert Opinion on Therapeutic Targets 21:7, pages 738-750.
Read now
Read now
HH Nordal, JG Brun, M Hordvik, M Eidsheim, R Jonsson & A-K Halse. (2016) Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab. Scandinavian Journal of Rheumatology 45:4, pages 274-281.
Read now
Read now
H. B. Hammer, E. A. Haavardsholm & T. K. Kvien. (2008) Calprotectin (a major leucocyte protein) is associated with the levels of anti‐CCP and rheumatoid factor in a longitudinal study of patients with very early rheumatoid arthritis. Scandinavian Journal of Rheumatology 37:3, pages 179-182.
Read now
Read now
C. Homann, E. Christensen, P. Schlichting, E. K. Philipsen, N. A. Graudal & P. Garred. (2003) Ascites Fluid and Plasma Calprotectin Concentrations in Liver Disease. Scandinavian Journal of Gastroenterology 38:4, pages 415-420.
Read now
Read now
John A. Olson, Marianne Forrester, Paul A. Clohessy, Barbara E. Golden, Richard Herriot & John V. Forrester. (1996) Calprotectin is raised in endogenous posterior uveitis. Ocular Immunology and Inflammation 4:2, pages 91-98.
Read now
Read now
J. G. Brun, M. Cuida, H. Jacobsen, R. Kloster, A. C. Johannesen, H. M. Høyeraal & R. Jonsson. (1994) Sjögren's Syndrome in Inflammatory Rheumatic Diseases: Analysis of the Leukocyte Protein Calprotectin in Plasma and Saliva. Scandinavian Journal of Rheumatology 23:3, pages 114-118.
Read now
Read now
Articles from other publishers (71)
Mari Kärki, Laura Tanner, Satu Lahtinen, Tero Soukka & Harri Niinikoski. (2023) Plasma calprotectin is extremely high in patients with lysinuric protein intolerance. JIMD Reports 64:4, pages 293-299.
Crossref
Crossref
Samantha Louise Smith, Sheree Alexander, Nisha Nair, Sebastien Viatte, Stephen Eyre, Kimme L Hyrich, Ann W Morgan, Anthony G Wilson, John D Isaacs, Darren Plant & Anne Barton. (2023) Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis. Annals of the Rheumatic Diseases 82:5, pages 611-620.
Crossref
Crossref
Gülden Sincan, Emel Ayvaz, Fuat Erdem & Ahmet Kiziltunç. (2023) The importance of serum calprotectin level in patients with lymphoma. Iraqi Journal of Hematology 12:1, pages 98.
Crossref
Crossref
José Inciarte-Mundo, Beatriz Frade-Sosa & Raimon Sanmartí. (2022) From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis. Frontiers in Immunology 13.
Crossref
Crossref
Nik Syazana Izyan Saffery, Krishnamurithy Genasan, Chee Ken Chan, Khairul Anwar Ayob, Seow Hui Teo, Mohamed Zubair Mohamed Al-Fayyadh, Iekhsan Othman, Syafiq Asnawi Zainal Abidin, Murali Malliga Raman, Hanumantha Rao Balaji Raghavendran & Tunku Kamarul. (2022) Typical response of CD14++CD16– monocyte to knee synovial derived mediators as a key target to overcome the onset and progression of osteoarthritis. Frontiers in Medicine 9.
Crossref
Crossref
Isaac T. Cheng, Huan Meng, Martin Li, Edmund K. Li, Priscilla C. Wong, Jack Lee, Bryan P. Yan, Alex P. W. Lee, Ho So & Lai-Shan Tam. (2022) Serum Calprotectin Level Is Independently Associated With Carotid Plaque Presence in Patients With Psoriatic Arthritis. Frontiers in Medicine 9.
Crossref
Crossref
Mona H. Abd Elsamea, Safaa A. Mahran, Asmaa N. Badr, Dalia T. Kamal & Tayseer M. Khidre. (2022) Evaluation of serum calprotectin level as a biomarker of disease activity in rheumatoid arthritis and osteoarthritis patients. The Egyptian Rheumatologist 44:3, pages 185-190.
Crossref
Crossref
Gholam Hossein Alishiri, Ramezan Ali Ataee, Mahsa Ramezanpour, Danial Chaleshi & Ehsan Rahmanian. (2022) Correlation between Serum Levels of Calprotectin with Disease Activity in Rheumatoid Arthritis Patients. Journal of Advances in Medical and Biomedical Research 30:140, pages 263-268.
Crossref
Crossref
Satoru Yui. (2022) Unintended Observations Leading to Macrophage Growth and Neutrophil Factor Research観察によって導かれたマクロファージ増殖及び好中球因子の研究. YAKUGAKU ZASSHI 142:3, pages 229-239.
Crossref
Crossref
Irene Di Ceglie, Peter L. E. M. van Lent, Edwin J. W. Geven, Marije I. Koenders, Arjen B. Blom, Thomas Vogl, Johannes Roth & Martijn H. J. van den Bosch. (2021) S100A8/A9 is not essential for the development of inflammation and joint pathology in interleukin-1 receptor antagonist knockout mice. Arthritis Research & Therapy 23:1.
Crossref
Crossref
Emma Altobelli, Paolo Matteo Angeletti, Reimondo Petrocelli, Giuseppe Lapergola, Giovanni Farello, Giovanni Cannataro & Luciana Breda. (2021) Serum Calprotectin a Potential Biomarker in Juvenile Idiopathic Arthritis: A Meta-Analysis. Journal of Clinical Medicine 10:21, pages 4861.
Crossref
Crossref
Mauro Giuffrè, Luigi Vetrugno, Stefano Di Bella, Rita Moretti, Debora Berretti & Lory Saveria Crocè. (2021) Calprotectin and SARS-CoV-2: A Brief-Report of the Current Literature. Healthcare 9:8, pages 956.
Crossref
Crossref
Ahmed R. Radwan, Ahmed Allam & Abdullah Radwan. (2021) The relationship of serum calprotectin with disease activity, functional status, ultrasonographic findings and radiological damage in rheumatoid arthritis patients. The Egyptian Rheumatologist 43:2, pages 147-151.
Crossref
Crossref
Ourania S. Kotsiou, Dimitrios Papagiannis, Rodanthi Papadopoulou & Konstantinos I. Gourgoulianis. (2021) Calprotectin in Lung Diseases. International Journal of Molecular Sciences 22:4, pages 1706.
Crossref
Crossref
Hui Shi, Yu Zuo, Srilakshmi Yalavarthi, Kelsey Gockman, Melanie Zuo, Jacqueline A Madison, Christopher Blair, Wrenn Woodward, Sean P Lezak, Njira L Lugogo, Robert J Woods, Christian Lood, Jason S Knight & Yogendra Kanthi. (2021) Neutrophil calprotectin identifies severe pulmonary disease in COVID-19. Journal of Leukocyte Biology 109:1, pages 67-72.
Crossref
Crossref
Matthias Jarlborg, Delphine S. Courvoisier, Céline Lamacchia, Laura Martinez Prat, Michael Mahler, Chelsea Bentow, Axel Finckh, Cem Gabay & Michael J. Nissen. (2020) Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis. Arthritis Research & Therapy 22:1.
Crossref
Crossref
Magne Kristoffer Fagerhol, Egil Johnson, Jon‐Magnus Tangen, Ivana Hollan, Mohammad Reza Mirlashari, Lise Sofie Haug Nissen‐Meyer & Geir Hetland. (2020) NETs analysed by novel calprotectin‐based assays in blood donors and patients with multiple myeloma or rheumatoid arthritis: A pilot study. Scandinavian Journal of Immunology 91:5.
Crossref
Crossref
Qin Wang, Weiqian Chen & Jin Lin. (2019) The role of calprotectin in rheumatoid arthritis. Journal of Translational Internal Medicine 7:4, pages 126-131.
Crossref
Crossref
N. Jung, J.-L. Bueb, F. Tolle & S. Bréchard. (2019) Regulation of neutrophil pro-inflammatory functions sheds new light on the pathogenesis of rheumatoid arthritis. Biochemical Pharmacology 165, pages 170-180.
Crossref
Crossref
Jana Hurnakova, Hana Hulejova, Jakub Zavada, Martin Komarc, Lucie Andres Cerezo, Herman Mann, Jiri Vencovsky, Karel Pavelka & Ladislav Senolt. (2018) Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein. Clinical Rheumatology 37:8, pages 2055-2062.
Crossref
Crossref
Maria Karolina Jonsson, Nina Paulshus Sundlisæter, Hilde Haugedal Nordal, Hilde Berner Hammer, Anna-Birgitte Aga, Inge Christoffer Olsen, Karl Albert Brokstad, Désirée van der Heijde, Tore K Kvien, Bjørg-Tilde Svanes Fevang, Siri Lillegraven & Espen A Haavardsholm. (2017) Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis. Annals of the Rheumatic Diseases 76:12, pages 2031-2037.
Crossref
Crossref
Niklas Jonsson, Tom Nilsen, Patrik Gille-Johnson, Max Bell, Claes-Roland Martling, Anders Larsson & Johan Mårtensson. (2017) Calprotectin as an early biomarker of bacterial infections in critically ill patients: an exploratory cohort assessment. Critical Care and Resuscitation 19:3, pages 205-213.e2.
Crossref
Crossref
Jana Hurnakova, Hana Hulejova, Jakub Zavada, Petra Hanova, Martin Komarc, Herman Mann, Martin Klein, Olga Sleglova, Marta Olejarova, Sarka Forejtova, Olga Ruzickova, Jiri Vencovsky, Karel Pavelka & Ladislav Senolt. (2017) Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study. PLOS ONE 12:8, pages e0183420.
Crossref
Crossref
Tomohisa Kato, Hideaki Kouzaki, Koji Matsumoto, Junichi Hosoi & Takeshi Shimizu. (2017) The effect of calprotectin on TSLP and IL-25 production from airway epithelial cells. Allergology International 66:2, pages 281-289.
Crossref
Crossref
Magdalena Kopeć-Mędrek, Małgorzata Widuchowska & Eugeniusz J. Kucharz. (2016) Calprotectin in rheumatic diseases: a review. Rheumatology 54:6, pages 306-309.
Crossref
Crossref
José Inciarte-Mundo, Julio Ramirez, Maria Victoria Hernández, Virginia Ruiz-Esquide, Andrea Cuervo, Sonia Raquel Cabrera-Villalba, Mariona Pascal, Jordi Yagüe, Juan D. Cañete & Raimon Sanmarti. (2016) Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity. Arthritis Research & Therapy 18:1.
Crossref
Crossref
Ayse Acar, Savas Guzel, Banu Sarifakioglu, Eda Celik Guzel, Aliye Yildirim Guzelant, Ceyda Karadag & Lebriz Kiziler. (2016) Calprotectin levels in patients with rheumatoid arthritis to assess and association with exercise treatment. Clinical Rheumatology 35:11, pages 2685-2692.
Crossref
Crossref
Oscar R. Herrera, Michael L. Christensen & Richard A. Helms. (2016) Calprotectin: Clinical Applications in Pediatrics. The Journal of Pediatric Pharmacology and Therapeutics 21:4, pages 308-321.
Crossref
Crossref
José Inciarte-Mundo, Maria Victoria Hernández, Virginia Ruiz-Esquide, Sonia Raquel Cabrera-Villalba, Julio Ramirez, Andrea Cuervo, Mariona Pascal, Jordi Yagüe, Juan D. Cañete & Raimon Sanmarti. (2016) Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors. Arthritis Care & Research 68:7, pages 899-906.
Crossref
Crossref
José Inciarte-Mundo, Virginia Ruiz-Esquide, Maria Victoria Hernández, Juan D. Cañete, Sonia Raquel Cabrera-Villalba, Julio Ramirez, Jordi Yagüe & Raimon Sanmarti. (2015) Calprotectin more accurately discriminates the disease status of rheumatoid arthritis patients receiving tocilizumab than acute phase reactants. Rheumatology, pages kev251.
Crossref
Crossref
Mads Abildtrup, Gabrielle H. Kingsley & David L. Scott. (2015) Calprotectin as a Biomarker for Rheumatoid Arthritis: A Systematic Review. The Journal of Rheumatology 42:5, pages 760-770.
Crossref
Crossref
Ivy Y Choi, Danielle M Gerlag, Marieke J Herenius, Rogier M Thurlings, Carla A Wijbrandts, Dirk Foell, Thomas Vogl, Johannes Roth, Paul P Tak & Dirk Holzinger. (2015) MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 74:3, pages 499-505.
Crossref
Crossref
Peter Kruzliak, Jan Novák, Miroslav Novák & George J. Fodor. (2014) Role of calprotectin in cardiometabolic diseases. Cytokine & Growth Factor Reviews 25:1, pages 67-75.
Crossref
Crossref
Ömer F. BeşerSelim SancakTülay ErkanTufan KutluHaluk ÇokuğraşFügen Ç. Çokuğraş. (2014) Can Fecal Calprotectin Level Be Used as a Markers of Inflammation in the Diagnosis and Follow-Up of Cow's Milk Protein Allergy?. Allergy, Asthma & Immunology Research 6:1, pages 33.
Crossref
Crossref
Tae-Hyeong Lee, An-Soo Jang, Jong-Sook Park, Tae-Hoon Kim, Young Suk Choi, Hye-rim Shin, Sung-Woo Park, Soo-Taek Uh, Jae-Sung Choi, Young Hoon Kim, YongBae Kim, Sungryul Kim, Il Yup Chung, Sung Hwan Jeong & Choon-Sik Park. (2013) Elevation of S100 calcium binding protein A9 in sputum of neutrophilic inflammation in severe uncontrolled asthma. Annals of Allergy, Asthma & Immunology 111:4, pages 268-275.e1.
Crossref
Crossref
Maria Filippa Addis, Salvatore Pisanu, Gavino Marogna, Tiziana Cubeddu, Daniela Pagnozzi, Carla Cacciotto, Franca Campesi, Giuseppe Schianchi, Stefano Rocca & Sergio Uzzau. (2013) Production and Release of Antimicrobial and Immune Defense Proteins by Mammary Epithelial Cells following Streptococcus uberis Infection of Sheep. Infection and Immunity 81:9, pages 3182-3197.
Crossref
Crossref
Miriam García-Arias, Dora Pascual-Salcedo, Susana Ramiro, Marie-Eve Ueberschlag, Thomas M. Jermann, Carlos Cara, Emilio Martín-Mola & Alejandro Balsa. (2013) Calprotectin in Rheumatoid Arthritis. Molecular Diagnosis & Therapy 17:1, pages 49-56.
Crossref
Crossref
Taina Sipponen. (2013) Diagnostics and Prognostics of Inflammatory Bowel Disease with Fecal Neutrophil-Derived Biomarkers Calprotectin and Lactoferrin. Digestive Diseases 31:3-4, pages 336-344.
Crossref
Crossref
Ladislav Šenolt. (2012) Calprotectin (a S100 protein) as a sensitive biomarker for rheumatoid arthritis: new perspectives for an old finding. International Journal of Clinical Rheumatology 7:2, pages 127-129.
Crossref
Crossref
Hilde Hammer, Magne K Fagerhol, Tale Wien & Tore K Kvien. (2011) The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab. Arthritis Research & Therapy 13:5, pages R178.
Crossref
Crossref
Kuo-Hsun Chiu, Wen-Lian William Lee, Chih-Ching Chang, San-Cher Chen, Yu-Chen Chang, Mei-Ning Ho, Jing-Fang Hsu & Pao-Chi Liao. (2010) A label-free differential proteomic analysis of mouse bronchoalveolar lavage fluid exposed to ultrafine carbon black. Analytica Chimica Acta 673:2, pages 160-166.
Crossref
Crossref
E. Andersen, I. M. Dessaix, T. Perneger & A. Mombelli. (2010) Myeloid-related protein (MRP8/14) expression in gingival crevice fluid in periodontal health and disease and after treatment. Journal of Periodontal Research.
Crossref
Crossref
Chandima Perera, H Patrick McNeil & Carolyn L Geczy. (2009) S100 Calgranulins in inflammatory arthritis. Immunology & Cell Biology 88:1, pages 41-49.
Crossref
Crossref
Andrew J. HalaykoSaeid Ghavami. (2009) S100A8/A9: a mediator of severe asthma pathogenesis and morbidity?This article is one of a selection of papers published in a special issue celebrating the 125th anniversary of the Faculty of Medicine at the University of Manitoba.. Canadian Journal of Physiology and Pharmacology 87:10, pages 743-755.
Crossref
Crossref
Jan M Ehrchen, Cord Sunderkötter, Dirk Foell, Thomas Vogl & Johannes Roth. (2009) The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. Journal of Leukocyte Biology 86:3, pages 557-566.
Crossref
Crossref
Jørgen Jahnsen, Arne Røseth & Erling Aadland. (2009) Måling av kalprotektin i feces. Tidsskrift for Den norske legeforening 129:8, pages 743-745.
Crossref
Crossref
Marie-Astrid Raquil, Nadia Anceriz, Pascal Rouleau & Philippe A. Tessier. (2008) Blockade of Antimicrobial Proteins S100A8 and S100A9 Inhibits Phagocyte Migration to the Alveoli in Streptococcal Pneumonia. The Journal of Immunology 180:5, pages 3366-3374.
Crossref
Crossref
Peter Olofsson, Annika Nerstedt, Malin Hultqvist, Elisabeth C Nilsson, Sofia Andersson, Anna Bergelin & Rikard Holmdahl. (2007) Arthritis suppression by NADPH activation operates through an interferon-β pathway. BMC Biology 5:1.
Crossref
Crossref
Reza Yousefi, Mehdi Imani, Susan K. Ardestani, Ali Akbar Saboury, Nematollah Gheibi & Bijan Ranjbar. (2007) Human Calprotectin: Effect of Calcium and Zinc on its Secondary and Tertiary Structures, and Role of pH in its Thermal Stability. Acta Biochimica et Biophysica Sinica 39:10, pages 795-802.
Crossref
Crossref
A. Larsen, I. B. Bronstein, O. Dahl, T. Wentzel-Larsen, E. K. Kristoffersen & M. K. Fagerhol. (2007) Quantification of S100A12 (EN-RAGE) in Blood Varies with Sampling Method, Calcium and Heparin. Scandinavian Journal of Immunology 65:2, pages 192-201.
Crossref
Crossref
Dirk Foell, Helmut Wittkowski, Thomas Vogl & Johannes Roth. (2007) S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. Journal of Leukocyte Biology 81:1, pages 28-37.
Crossref
Crossref
Reza Yousefi, Susan K. Ardestani, Ali Akbar Saboury, Amina Kariminia, Madjid Zeinali & Mojtaba Amani. (2005) Investigation on the Surface Hydrophobicity and Aggregation Kinetics of Human Calprotectin in the Presence of Calcium. BMB Reports 38:4, pages 407-413.
Crossref
Crossref
Dirk Foell & Johannes Roth. (2004) Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis & Rheumatism 50:12, pages 3762-3771.
Crossref
Crossref
Dirk Foell, Michael Frosch, Clemens Sorg & Johannes Roth. (2004) Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clinica Chimica Acta 344:1-2, pages 37-51.
Crossref
Crossref
Cord H. Sunderkotter, Jane Tomimori-Yamashita, Verena Nix, Solange M. Maeda, Anca Sindrilaru, Mario Mariano, Clemens Sorg & Johannes Roth. (2004) High expression of myeloid-related proteins 8 and 14 characterizes an inflammatorily active but ineffective response of macrophages during leprosy. Immunology 111:4, pages 472-480.
Crossref
Crossref
Ali Ahmad, Darren L. Bayley, Shiping He & Robert A. Stockley. (2003) Myeloid Related Protein-8/14 Stimulates Interleukin-8 Production in Airway Epithelial Cells. American Journal of Respiratory Cell and Molecular Biology 29:4, pages 523-530.
Crossref
Crossref
Ulrika Lorentzon Fagerberg, Lars Lööf, Rumjana Djilali Merzoug, Lars-Olof Hansson & Yigael Finkel. (2003) Fecal Calprotectin Levels in Healthy Children Studied With an Improved Assay. Journal of Pediatric Gastroenterology and Nutrition 37:4, pages 468-472.
Crossref
Crossref
David Kane, Johannes Roth, Michael Frosch, Thomas Vogl, Barry Bresnihan & Oliver FitzGerald. (2003) Increased perivascular synovial membrane expression of myeloid‐related proteins in psoriatic arthritis. Arthritis & Rheumatism 48:6, pages 1676-1685.
Crossref
Crossref
Satoru Yui, Yuichi Nakatani & Masaaki Mikami. (2003) Calprotectin (S100A8/S100A9), an Inflammatory Protein Complex from Neutrophils with a Broad Apoptosis-Inducing Activity. Biological and Pharmaceutical Bulletin 26:6, pages 753-760.
Crossref
Crossref
Zheng Yang, Tony Tao, Mark J Raftery, Peter Youssef, Nick Di Girolamo & Carolyn L Geczy. (2001) Proinflammatory properties of the human S100 protein S100A12. Journal of Leukocyte Biology 69:6, pages 986-994.
Crossref
Crossref
Paul J Limburg, David A Ahlquist, William J Sandborn, Douglas W Mahoney, Mary E Devens, Jonathan J Harrington & Alan R Zinsmeister. (2000) Fecal Calprotectin Levels Predict Colorectal Inflammation Among Patients With Chronic Diarrhea Referred for Colonoscopy. American Journal of Gastroenterology 95:10, pages 2831-2837.
Crossref
Crossref
Craig A. Harrison, Mark J. Raftery, John Walsh, Paul Alewood, Siiri E. Iismaa, Soula Thliveris & Carolyn L. Geczy. (1999) Oxidation Regulates the Inflammatory Properties of the Murine S100 Protein S100A8. Journal of Biological Chemistry 274:13, pages 8561-8569.
Crossref
Crossref
Satoru Yui, Masaaki Mikami, Mikio Kitahara & Masatoshi Yamazaki. (1998) The inhibitory effect of lycorine on tumor cell apoptosis induced by polymorphonuclear leukocyte-derived calprotectin. Immunopharmacology 40:2, pages 151-162.
Crossref
Crossref
Masaaki Mikami, Masatoshi Yamazaki & Satoru Yui. (2013) Kinetical Analysis of Tumor Cell Death‐Inducing Mechanism by Polymorphonuclear Leukocyte‐Derived Calprotectin: Involvement of Protein Synthesis and Generation of Reactive Oxygen Species in Target Cells. Microbiology and Immunology 42:3, pages 211-221.
Crossref
Crossref
B Johne, M K Fagerhol, T Lyberg, H Prydz, P Brandtzaeg, C F Naess-Andresen & I Dale. (1997) Functional and clinical aspects of the myelomonocyte protein calprotectin.. Molecular Pathology 50:3, pages 113-123.
Crossref
Crossref
Aislinn Rice, James Grimshaw, Jadwiga Trocha-Grimshaw, Philip McCarron & G.Brian Wisdom. (1997) Identification of α1-acid glycoprotein (orosomucoid) in human synovial fluid by capillary electrophoresis. Journal of Chromatography A 772:1-2, pages 305-311.
Crossref
Crossref
Mihaela Cuida, Johan G. Brun, Anne Christine Johannessen & Roland Jonsson. (1996) Immunohistochemical characterization of the cellular infiltrates in Sjögren's syndrome, rheumatoid arthritis and osteoarthritis with special reference to calprotectin-producing cells. APMIS 104:7-8, pages 881-890.
Crossref
Crossref
JOHAN G. Brun, GEIR HÅLand, HANS-JACOB Haga, MAGNE K. Fagerhol & ROLAND Jonsson. (1995) Effects of calprotectin in avridine-induced arthritis. APMIS 103:1-6, pages 233-240.
Crossref
Crossref
J. G. BRUN, E. ULVESTAD, M. K. FAGERHOL & R. JONSSON. (2006)
Effects of Human Calprotectin (L1) on
In Vitro
Immunoglobulin Synthesis
. Scandinavian Journal of Immunology 40:6, pages 675-680.
Crossref
Crossref
Ivan G. Otterness. (1994) The value of C-reactive protein measurement in rheumatoid arthritis. Seminars in Arthritis and Rheumatism 24:2, pages 91-104.
Crossref
Crossref
Hans-Jacob Haga, Johan G. Brun, Hilde Berner Berntzen, Ricard Cervera, Munther Khamashta & Graham R.V. Hughes. (2016) Calprotectin in Patients with Systemic Lupus Erythematosus: Relation to Clinical and Laboratory Parameters of Disease Activity. Lupus 2:1, pages 47-50.
Crossref
Crossref